<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="editorial" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJE</journal-id>
<journal-title-group>
<journal-title>International Journal of Epigenetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">[--Add issn ppub at final stage--]</issn>
<issn pub-type="epub">[--Add issn epub at final stage--]</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">IJE-0-0-00001</article-id>
<article-id pub-id-type="doi">10.3892/ije.2020.1</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Editorial</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Epigenetics</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Vlachakis</surname><given-names>Dimitrios</given-names></name>
<xref rid="af1-ije-0-0-00001" ref-type="aff">1</xref>
<xref rid="af2-ije-0-0-00001" ref-type="aff">2</xref>
<xref rid="af3-ije-0-0-00001" ref-type="aff">3</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Chrousos</surname><given-names>George P.</given-names></name>
<xref rid="af2-ije-0-0-00001" ref-type="aff">2</xref>
<xref rid="af3-ije-0-0-00001" ref-type="aff">3</xref>
<xref rid="c1-ije-0-0-00001" ref-type="corresp"/>
</contrib>
</contrib-group>
<aff id="af1-ije-0-0-00001"><label>1</label>Laboratory of Genetics, Department of Biotechnology, School of Applied Biology and Biotechnology, Agricultural University of Athens, 11855 Athens, Greece</aff>
<aff id="af2-ije-0-0-00001"><label>2</label>University Research Institute of Maternal and Child Health and Precision Medicine, and UNESCO Chair on Adolescent Health Care, National and Kapodistrian University of Athens, &#x2018;Aghia Sophia&#x2019; Children&#x0027;s Hospital, 11527 Athens, Greece</aff>
<aff id="af3-ije-0-0-00001"><label>3</label>Division of Endocrinology and Metabolism, Center of Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, 11527 Athens, Greece</aff>
<author-notes>
<corresp id="c1-ije-0-0-00001"><italic>Correspondence to:</italic> Professor George P. Chrousos, University Research Institute of Maternal and Child Health and Precision Medicine, and UNESCO Chair on Adolescent Health Care, National and Kapodistrian University of Athens, &#x2018;Aghia Sophia&#x2019; Children&#x0027;s Hospital, 11527 Athens, Greece <email>chrousos@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>01</month>
<year>2021</year></pub-date>
<pub-date pub-type="epub">
<day>03</day>
<month>12</month>
<year>2020</year></pub-date>
<volume>1</volume>
<issue>1</issue>
<elocation-id>1</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>10</month>
<year>2020</year></date>
<date date-type="accepted">
<day>02</day>
<month>12</month>
<year>2020</year></date>
</history>
<permissions>
<copyright-statement>Copyright: &#x00A9; Vlachakis et al.</copyright-statement>
<copyright-year>2020</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license>
</permissions>
<abstract>
<p>&#x00A0;</p>
</abstract>
<kwd-group>
<kwd>epigenetics</kwd>
<kwd>genomics</kwd>
<kwd>gene regulation</kwd>
<kwd>gene expression</kwd>
<kwd>DNA methylation</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec>
<title/>
<p>All cell types of an organism contain the same genetic information, but showcase distinct functions and characteristics (<xref rid="b1-ije-0-0-00001" ref-type="bibr">1</xref>). Cell phenotypes are determined by mechanisms that regulate which genes are expressed and which are silenced, termed epigenetic mechanisms (<xref rid="b2-ije-0-0-00001" ref-type="bibr">2</xref>). Epigenetics refer to the study of mechanisms and molecules that can perpetuate alternative gene activity states in the context of unaltered DNA sequence (<xref rid="b3-ije-0-0-00001" ref-type="bibr">3</xref>). The key factors describing epigenetics are heritability and reversibility (<xref rid="b4-ije-0-0-00001" ref-type="bibr">4</xref>). The mechanisms underlying epigenetic regulation include DNA methylation, histone modification, chromatin remodeling, non-coding RNA activity and the interplay amongst these (<xref rid="b5-ije-0-0-00001" ref-type="bibr">5</xref>). The key characteristics of epigenetics have generated immense research interest for possible applications in various biological fields.</p>
<p>The high interest in epigenetic research, in conjunction with the impressive technological leaps over the past decade, has allowed for the high throughput mapping of epigenetic alterations. Specifically, epigenomics allows the study of the effects of epigenetic alterations on the genetic material of a cell, termed the epigenome (<xref rid="b6-ije-0-0-00001" ref-type="bibr">6</xref>). In humans, epigenetic tests can, in principle, provide information on an individual&#x0027;s disease risk profile, a patient&#x0027;s response to treatment, and exposure to physicochemical and psychosocial disruptors of epigenetic mechanisms (<xref rid="b7-ije-0-0-00001" ref-type="bibr">7</xref>). Furthermore, such tests can elucidate the complexities characterizing epigenetic regulation.</p>
<p>Epigenetic irregularities like abnormal DNA methylation, histone modifications, or RNA silencing are observed in several human diseases, while genetic mutations that alter the epigenetic machinery can also cause pathologies (<xref rid="b8-ije-0-0-00001" ref-type="bibr">8</xref>). A prime example is cancer, where deregulation of epigenetic mechanisms can lead to oncogene activation or tumor suppressor gene inactivation, allowing cells to acquire characteristics that are hallmarks of cancer (<xref rid="b9-ije-0-0-00001" ref-type="bibr">9</xref>,<xref rid="b10-ije-0-0-00001" ref-type="bibr">10</xref>). Another example is neurodegenerative diseases. Specifically, since virtually all neurodegenerative diseases are associated with aging, it is hypothesized that epigenetic alterations accumulate through time until repair mechanisms and stress-response pathways are unable to counteract mentioned changes, leading to irreversible neurological damage (<xref rid="b11-ije-0-0-00001" ref-type="bibr">11</xref>). These are not the only diseases associated with the deregulation of epigenetic mechanisms, with some other examples being autoimmune and inflammatory diseases (<xref rid="b12-ije-0-0-00001" ref-type="bibr">12</xref>), cardiovascular disease (<xref rid="b13-ije-0-0-00001" ref-type="bibr">13</xref>), and metabolic disorders (<xref rid="b14-ije-0-0-00001" ref-type="bibr">14</xref>). The involvement of epigenetic mechanisms in so many diseases lays the foundation for the development of epigenetics-based drugs and biomarkers. Epigenetics-based drugs are highly appealing since epigenetic marks are reversible (<xref rid="b15-ije-0-0-00001" ref-type="bibr">15</xref>). Currently, a number of drugs targeting epigenetic enzymes and analogues of epigenetic modifications have already been introduced to clinical use, while other epigenetics-based drugs are in the clinical trial phase (<xref rid="b16-ije-0-0-00001" ref-type="bibr">16</xref>). Also, as mentioned above, epigenetic modulators are very intriguing disease biomarkers. These biomarkers showcase plenty of advantages since they can explain various differences in patient endophenotypes while incorporating information in relation to the effects of the environment and lifestyle on health and disease (<xref rid="b17-ije-0-0-00001" ref-type="bibr">17</xref>). Therefore, epigenetics could potentially become an essential part of the emerging field of personalized medicine (<xref rid="b18-ije-0-0-00001" ref-type="bibr">18</xref>).</p>
<p>Apart from medicine, epigenetics has also taken center stage in agricultural sciences. Regarding plants, studies conducted under laboratory conditions on model organisms have explored how epigenetics influence plant life, while studying non-model organisms in complex environments can produce novel evolutionary and ecological information (<xref rid="b19-ije-0-0-00001" ref-type="bibr">19</xref>). Epigenetics affect agronomically important plant traits, such as flowering time, fruit development, plant immunity and responses to environmental factors. The elucidation of the mechanisms underlying plant epigenetics can provide tools that can be used for crop improvement and productivity increase with regards to the environmental conditions (<xref rid="b20-ije-0-0-00001" ref-type="bibr">20</xref>). Moreover, epigenetics could potentially be used to improve livestock management and selection. Specific management and nutritional strategies could promote favorable epigenotypes in the livestock population, leading to better quality products and higher productivity (<xref rid="b21-ije-0-0-00001" ref-type="bibr">21</xref>).</p>
<p>Additionally, the advancement of epigenetics seems also to influence social sciences. Scientists may find in epigenetics a causal link between social adversities and health discrepancies (<xref rid="b22-ije-0-0-00001" ref-type="bibr">22</xref>). The establishment of such associations could lead to the reorganization of political and clinical fields in order to accompany developments in epigenetics (<xref rid="b23-ije-0-0-00001" ref-type="bibr">23</xref>). Moreover, epigenetics could become the basis for novel economic theories (<xref rid="b24-ije-0-0-00001" ref-type="bibr">24</xref>), which in turn may influence essential economic policies. Lastly, epigenetics may influence the field of psychology, especially since they showcase the influence of behavior and environment in human development, which could provide novel information on the development of mental disorders as well as therapeutic approaches (<xref rid="b25-ije-0-0-00001" ref-type="bibr">25</xref>).</p>
<p>All in all, epigenetics seems to be a case of paradigm shift influencing the basic assumptions driving various scientific fields.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>Not applicable.</p>
</ack>
<sec>
<title>Funding</title>
<p>No funding was received.</p>
</sec>
<sec>
<title>Availability of data and materials</title>
<p>Not applicable.</p>
</sec>
<sec>
<title>Authors&#x0027; contributions</title>
<p>DV and GPC both equally contributed to the writing, drafting, revising, editing, reviewing, and the conception and design of the Editorial. All authors read and approved the final manuscript.</p>
</sec>
<sec>
<title>Ethics approval and consent to participate</title>
<p>Not applicable.</p>
</sec>
<sec>
<title>Patient consent for publication</title>
<p>Not applicable.</p>
</sec>
<sec>
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="b1-ije-0-0-00001"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanna</surname><given-names>CW</given-names></name><name><surname>Demond</surname><given-names>H</given-names></name><name><surname>Kelsey</surname><given-names>G</given-names></name></person-group><article-title>Epigenetic regulation in development: Is the mouse a good model for the human?</article-title><source>Hum Reprod Update</source><volume>24</volume><fpage>556</fpage><lpage>576</lpage><year>2018</year><pub-id pub-id-type="pmid">29992283</pub-id><pub-id pub-id-type="doi">10.1093/humupd/dmy021</pub-id></element-citation></ref>
<ref id="b2-ije-0-0-00001"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polli</surname><given-names>A</given-names></name><name><surname>Ickmans</surname><given-names>K</given-names></name><name><surname>Godderis</surname><given-names>L</given-names></name><name><surname>Nijs</surname><given-names>J</given-names></name></person-group><article-title>When environment meets genetics: a clinical review of the epigenetics of pain, psychological factors, and physical activity</article-title><source>Arch Phys Med Rehabil</source><volume>100</volume><fpage>1153</fpage><lpage>1161</lpage><year>2019</year><pub-id pub-id-type="pmid">30352223</pub-id><pub-id pub-id-type="doi">10.1016/j.apmr.2018.09.118</pub-id></element-citation></ref>
<ref id="b3-ije-0-0-00001"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavalli</surname><given-names>G</given-names></name><name><surname>Heard</surname><given-names>E</given-names></name></person-group><article-title>Advances in epigenetics link genetics to the environment and disease</article-title><source>Nature</source><volume>571</volume><fpage>489</fpage><lpage>499</lpage><year>2019</year><pub-id pub-id-type="pmid">31341302</pub-id><pub-id pub-id-type="doi">10.1038/s41586-019-1411-0</pub-id></element-citation></ref>
<ref id="b4-ije-0-0-00001"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>John</surname><given-names>RM</given-names></name><name><surname>Rougeulle</surname><given-names>C</given-names></name></person-group><article-title>Developmental epigenetics: phenotype and the flexible epigenome</article-title><source>Front Cell Dev Biol</source><volume>6</volume><issue>130</issue><year>2018</year><pub-id pub-id-type="pmid">30364270</pub-id><pub-id pub-id-type="doi">10.3389/fcell.2018.00130</pub-id></element-citation></ref>
<ref id="b5-ije-0-0-00001"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fardi</surname><given-names>M</given-names></name><name><surname>Solali</surname><given-names>S</given-names></name><name><surname>Farshdousti Hagh</surname><given-names>M</given-names></name></person-group><article-title>Epigenetic mechanisms as a new approach in cancer treatment: An updated review</article-title><source>Genes Dis</source><volume>5</volume><fpage>304</fpage><lpage>311</lpage><year>2018</year><pub-id pub-id-type="pmid">30591931</pub-id><pub-id pub-id-type="doi">10.1016/j.gendis.2018.06.003</pub-id></element-citation></ref>
<ref id="b6-ije-0-0-00001"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>KC</given-names></name><name><surname>Chang</surname><given-names>HY</given-names></name></person-group><article-title>Epigenomics: technologies and applications</article-title><source>Circ Res</source><volume>122</volume><fpage>1191</fpage><lpage>1199</lpage><year>2018</year><pub-id pub-id-type="pmid">29700067</pub-id><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.118.310998</pub-id></element-citation></ref>
<ref id="b7-ije-0-0-00001"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dupras</surname><given-names>C</given-names></name><name><surname>Song</surname><given-names>L</given-names></name><name><surname>Saulnier</surname><given-names>KM</given-names></name><name><surname>Joly</surname><given-names>Y</given-names></name></person-group><article-title>Epigenetic discrimination: emerging applications of epigenetics pointing to the limitations of policies against genetic discrimination</article-title><source>Front Genet</source><volume>9</volume><issue>202</issue><year>2018</year><pub-id pub-id-type="pmid">29937773</pub-id><pub-id pub-id-type="doi">10.3389/fgene.2018.00202</pub-id></element-citation></ref>
<ref id="b8-ije-0-0-00001"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shamsi</surname><given-names>MB</given-names></name><name><surname>Firoz</surname><given-names>AS</given-names></name><name><surname>Imam</surname><given-names>SN</given-names></name><name><surname>Alzaman</surname><given-names>N</given-names></name><name><surname>Samman</surname><given-names>MA</given-names></name></person-group><article-title>Epigenetics of human diseases and scope in future therapeutics</article-title><source>J Taibah Univ Med Sci</source><volume>12</volume><fpage>205</fpage><lpage>211</lpage><year>2017</year><pub-id pub-id-type="pmid">31435241</pub-id><pub-id pub-id-type="doi">10.1016/j.jtumed.2017.04.003</pub-id></element-citation></ref>
<ref id="b9-ije-0-0-00001"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nebbioso</surname><given-names>A</given-names></name><name><surname>Tambaro</surname><given-names>FP</given-names></name><name><surname>Dell&#x0027;Aversana</surname><given-names>C</given-names></name><name><surname>Altucci</surname><given-names>L</given-names></name></person-group><article-title>Cancer epigenetics: Moving forward</article-title><source>PLoS Genet</source><volume>14</volume><issue>e1007362</issue><year>2018</year><pub-id pub-id-type="pmid">29879107</pub-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1007362</pub-id></element-citation></ref>
<ref id="b10-ije-0-0-00001"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spandidos</surname><given-names>DA</given-names></name></person-group><article-title>A unified theory for the development of cancer</article-title><source>Biosci Rep</source><volume>6</volume><fpage>691</fpage><lpage>708</lpage><year>1986</year><pub-id pub-id-type="pmid">3545313</pub-id><pub-id pub-id-type="doi">10.1007/BF01116536</pub-id></element-citation></ref>
<ref id="b11-ije-0-0-00001"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berson</surname><given-names>A</given-names></name><name><surname>Nativio</surname><given-names>R</given-names></name><name><surname>Berger</surname><given-names>SL</given-names></name><name><surname>Bonini</surname><given-names>NM</given-names></name></person-group><article-title>Epigenetic regulation in neurodegenerative diseases</article-title><source>Trends Neurosci</source><volume>41</volume><fpage>587</fpage><lpage>598</lpage><year>2018</year><pub-id pub-id-type="pmid">29885742</pub-id><pub-id pub-id-type="doi">10.1016/j.tins.2018.05.005</pub-id></element-citation></ref>
<ref id="b12-ije-0-0-00001"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Surace</surname><given-names>AEA</given-names></name><name><surname>Hedrich</surname><given-names>CM</given-names></name></person-group><article-title>The role of epigenetics in autoimmune/inflammatory disease</article-title><source>Front Immunol</source><volume>10</volume><issue>1525</issue><year>2019</year><pub-id pub-id-type="pmid">31333659</pub-id><pub-id pub-id-type="doi">10.3389/fimmu.2019.01525</pub-id></element-citation></ref>
<ref id="b13-ije-0-0-00001"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prasher</surname><given-names>D</given-names></name><name><surname>Greenway</surname><given-names>SC</given-names></name><name><surname>Singh</surname><given-names>RB</given-names></name></person-group><article-title>The impact of epigenetics on cardiovascular disease</article-title><source>Biochem Cell Biol</source><volume>98</volume><fpage>12</fpage><lpage>22</lpage><year>2020</year><pub-id pub-id-type="pmid">31112654</pub-id><pub-id pub-id-type="doi">10.1139/bcb-2019-0045</pub-id></element-citation></ref>
<ref id="b14-ije-0-0-00001"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tzika</surname><given-names>E</given-names></name><name><surname>Dreker</surname><given-names>T</given-names></name><name><surname>Imhof</surname><given-names>A</given-names></name></person-group><article-title>Epigenetics and metabolism in health and disease</article-title><source>Front Genet</source><volume>9</volume><issue>361</issue><year>2018</year><pub-id pub-id-type="pmid">30279699</pub-id><pub-id pub-id-type="doi">10.3389/fgene.2018.00361</pub-id></element-citation></ref>
<ref id="b15-ije-0-0-00001"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kronfol</surname><given-names>MM</given-names></name><name><surname>Dozmorov</surname><given-names>MG</given-names></name><name><surname>Huang</surname><given-names>R</given-names></name><name><surname>Slattum</surname><given-names>PW</given-names></name><name><surname>McClay</surname><given-names>JL</given-names></name></person-group><article-title>The role of epigenomics in personalized medicine</article-title><source>Expert Rev Precis Med Drug Dev</source><volume>2</volume><fpage>33</fpage><lpage>45</lpage><year>2017</year><pub-id pub-id-type="pmid">29276780</pub-id><pub-id pub-id-type="doi">10.1080/23808993.2017.1284557</pub-id></element-citation></ref>
<ref id="b16-ije-0-0-00001"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganesan</surname><given-names>A</given-names></name><name><surname>Arimondo</surname><given-names>PB</given-names></name><name><surname>Rots</surname><given-names>MG</given-names></name><name><surname>Jeronimo</surname><given-names>C</given-names></name><name><surname>Berdasco</surname><given-names>M</given-names></name></person-group><article-title>The timeline of epigenetic drug discovery: From reality to dreams</article-title><source>Clin Epigenetics</source><volume>11</volume><issue>174</issue><year>2019</year><pub-id pub-id-type="pmid">31791394</pub-id><pub-id pub-id-type="doi">10.1186/s13148-019-0776-0</pub-id></element-citation></ref>
<ref id="b17-ije-0-0-00001"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x00ED;a-Gim&#x00E9;nez</surname><given-names>JL</given-names></name><name><surname>Seco-Cervera</surname><given-names>M</given-names></name><name><surname>Tollefsbol</surname><given-names>TO</given-names></name><name><surname>Rom&#x00E1;-Mateo</surname><given-names>C</given-names></name><name><surname>Peir&#x00F3;-Chova</surname><given-names>L</given-names></name><name><surname>Lapunzina</surname><given-names>P</given-names></name><name><surname>Pallard&#x00F3;</surname><given-names>FV</given-names></name></person-group><article-title>Epigenetic biomarkers: Current strategies and future challenges for their use in the clinical laboratory</article-title><source>Crit Rev Clin Lab Sci</source><volume>54</volume><fpage>529</fpage><lpage>550</lpage><year>2017</year><pub-id pub-id-type="pmid">29226748</pub-id><pub-id pub-id-type="doi">10.1080/10408363.2017.1410520</pub-id></element-citation></ref>
<ref id="b18-ije-0-0-00001"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kabekkodu</surname><given-names>SP</given-names></name><name><surname>Chakrabarty</surname><given-names>S</given-names></name><name><surname>Ghosh</surname><given-names>S</given-names></name><name><surname>Brand</surname><given-names>A</given-names></name><name><surname>Satyamoorthy</surname><given-names>K</given-names></name></person-group><article-title>Epigenomics, pharmacoepigenomics, and personalized medicine in cervical cancer</article-title><source>Public Health Genomics</source><volume>20</volume><fpage>100</fpage><lpage>115</lpage><year>2017</year><pub-id pub-id-type="pmid">28521327</pub-id><pub-id pub-id-type="doi">10.1159/000475804</pub-id></element-citation></ref>
<ref id="b19-ije-0-0-00001"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heer</surname><given-names>K</given-names></name><name><surname>Mounger</surname><given-names>J</given-names></name><name><surname>Boquete</surname><given-names>MT</given-names></name><name><surname>Richards</surname><given-names>CL</given-names></name><name><surname>Opgenoorth</surname><given-names>L</given-names></name></person-group><article-title>The diversifying field of plant epigenetics</article-title><source>New Phytol</source><volume>217</volume><fpage>988</fpage><lpage>992</lpage><year>2018</year><pub-id pub-id-type="pmid">29334596</pub-id><pub-id pub-id-type="doi">10.1111/nph.14985</pub-id></element-citation></ref>
<ref id="b20-ije-0-0-00001"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>&#x00C1;lvarez-Venegas</surname><given-names>R</given-names></name><name><surname>De-la-Pe&#x00F1;a</surname><given-names>C</given-names></name></person-group><article-title>Editorial: Recent advances of epigenetics in crop biotechnology</article-title><source>Front Plant Sci</source><volume>7</volume><issue>413</issue><year>2016</year><pub-id pub-id-type="pmid">27066049</pub-id><pub-id pub-id-type="doi">10.3389/fpls.2016.00413</pub-id></element-citation></ref>
<ref id="b21-ije-0-0-00001"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonz&#x00E1;lez-Recio</surname><given-names>O</given-names></name><name><surname>Toro</surname><given-names>MA</given-names></name><name><surname>Bach</surname><given-names>A</given-names></name></person-group><article-title>Past, present, and future of epigenetics applied to livestock breeding</article-title><source>Front Genet</source><volume>6</volume><issue>305</issue><year>2015</year><pub-id pub-id-type="pmid">26442117</pub-id><pub-id pub-id-type="doi">10.3389/fgene.2015.00305</pub-id></element-citation></ref>
<ref id="b22-ije-0-0-00001"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Notterman</surname><given-names>DA</given-names></name><name><surname>Mitchell</surname><given-names>C</given-names></name></person-group><article-title>Epigenetics and understanding the impact of social determinants of health</article-title><source>Pediatr Clin North Am</source><volume>62</volume><fpage>1227</fpage><lpage>1240</lpage><year>2015</year><pub-id pub-id-type="pmid">26318949</pub-id><pub-id pub-id-type="doi">10.1016/j.pcl.2015.05.012</pub-id></element-citation></ref>
<ref id="b23-ije-0-0-00001"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pickersgill</surname><given-names>M</given-names></name><name><surname>Niew&#x00F6;hner</surname><given-names>J</given-names></name><name><surname>M&#x00FC;ller</surname><given-names>R</given-names></name><name><surname>Martin</surname><given-names>P</given-names></name><name><surname>Cunningham-Burley</surname><given-names>S</given-names></name></person-group><article-title>Mapping the new molecular landscape: Social dimensions of epigenetics</article-title><source>New Genet Soc</source><volume>32</volume><fpage>429</fpage><lpage>447</lpage><year>2013</year><pub-id pub-id-type="pmid">24482610</pub-id><pub-id pub-id-type="doi">10.1080/14636778.2013.861739</pub-id></element-citation></ref>
<ref id="b24-ije-0-0-00001"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrutia</surname><given-names>J</given-names></name><name><surname>Zabala-Iturriagagoitia</surname><given-names>JM</given-names></name></person-group><article-title>Towards an epigenetic understanding of evolutionary economics and evolutionary economic geography</article-title><source>Evol Inst Econ Rev</source><volume>15</volume><fpage>213</fpage><lpage>241</lpage><year>2018</year></element-citation></ref>
<ref id="b25-ije-0-0-00001"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonz&#x00E1;lez-Pardo</surname><given-names>H</given-names></name><name><surname>P&#x00E9;rez &#x00C1;lvarez</surname><given-names>M</given-names></name></person-group><article-title>Epigenetics and its implications for Psychology</article-title><source>Psicothema</source><volume>25</volume><fpage>3</fpage><lpage>12</lpage><year>2013</year><pub-id pub-id-type="pmid">23336536</pub-id><pub-id pub-id-type="doi">10.7334/psicothema2012.327</pub-id></element-citation></ref>
</ref-list>
</back>
</article>
